Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
European Journal of Cancer & Clinical Oncology|April 1, 1985
The inhibitory effect of 5-acetoxy-2-(4-acetoxyphenyl)-1-ethyl-3-methylindole (D 16726) on estrogen-dependent mammary tumorsE von Angerer, J Prekajac, M Berger
The Journal of Steroid Biochemistry and Molecular Biology|July 1, 1996
Effect of growth factors on estrogen receptor mediated gene expressionF Hafner, E Holler, E von Angerer
Archiv Der Pharmazie|August 1, 1994
[3-Substituted 2-phenylindoles: synthesis and biological properties]S Mahboobi, G Grothus, E von Angerer
Anti-Cancer Drug Design|June 1, 1989
Platinum complexes with a selective action on estrogen receptor-positive mammary tumorsE von Angerer, H Birnböck, N Knebel
Endocrine Regulations|March 1, 1994
The activity of epitestosterone in hormone dependent prostate tumour modelsA Maucher, E von Angerer, R Hampl, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1992
The effect of a combination of zindoxifene and cisplatin on Dunning R3327-G prostatic carcinomas of the ratE von Angerer, H Birnböck, M Kager, et al.
Archiv Der Pharmazie|October 1, 1991
[Antitumor platinum(II) complexes with substituted 2-aminomethylpyridine ligands]H Brunner, G Nerl, E von Angerer, et al.
Journal of Medicinal Chemistry|December 4, 1998
Methoxy-substituted 3-formyl-2-phenylindoles inhibit tubulin polymerizationR Gastpar, M Goldbrunner, D Marko, et al.
Archiv Der Pharmazie|July 1, 1990
3-(Cyclohexenonyl)-4-(4-hydroxyphenyl)-hexanes: antiandrogenes derived from the estrogen hexestrolC D Schiller, M R Schneider, E von Angerer
Pageof 6